Abstract:OBJECTIVE Large numbers of people with type 2 diabetes are obese. However, changes in cognition and related brain function in obese people with diabetes have not been characterized. Here, we investigated cognition, olfactory function, and odor-induced brain alterations in these patients and therapeutic effects of glucagon-like peptide 1 receptor agonists (GLP-1Ras) on their psychological behavior and olfactory networks. RESEARCH DESIGN AND METHODS Cognitive, olfactory, and odor-induced brain activation assessments were administered to 35 obese and 35 nonobese people with type 2 diabetes and 35 control subjects matched for age, sex, and education. Among them, 20 obese individuals with diabetes with inadequate glycemic control and metformin monotherapy received GLP-1Ra treatment for 3 months and were reassessed for metabolic, cognitive, olfactory, and neuroimaging changes. RESULTS Obese subjects with diabetes demonstrated lower general cognition and olfactory threshold scores, decreased left hippocampal activation, and disrupted seed-based functional connectivity with right insula compared with nonobese subjects with diabetes. Negative associations were found between adiposity and episodic memory and between fasting insulin and processing speed test time in diabetes. Mediation analyses showed that olfactory function and left hippocampus activation mediated these correlations. With 3-month GLP-1Ra treatment, obese subjects with diabetes exhibited improved Montreal Cognitive Assessment (MoCA) score, olfactory test total score, and enhanced odor-induced right parahippocampus activation. CONCLUSIONS Obese subjects with type 2 diabetes showed impaired cognition and dysfunctional olfaction and brain networks, the latter of which mediated adiposity in cognitive impairment of diabetes. GLP-1Ras ameliorated cognitive and olfactory abnormalities in obese subjects with diabetes, providing new perspectives for early diagnosis and therapeutic approaches for cognitive decrements in these patients.

Effect of metabolic diseases on emotional and cognitive functions and its potential mechanisms:research progress

Research Progress on the Role of Medium-Chain Fatty Acids in Improving Metabolic Syndrome by Regulating Intestinal Microecology

Emotional Disorder Induced by High Fat Diet and Progress in Drug Intervention

Diet-induced metabolic disturbances as modulators of brain homeostasis.

Neurocognitive correlates of metabolic dysregulation in individuals with mood disorders: a systematic review and meta-analysis

Olfactory Dysfunction Mediates Adiposity in Cognitive Impairment of Type 2 Diabetes: Insights From Clinical and Functional Neuroimaging Studies

Links Between Obesity-Induced Brain Insulin Resistance, Brain Mitochondrial Dysfunction, and Dementia

Metabolic memory: mechanisms and diseases

Progress of Metabonomic Study on Various Metabolic Diseases

Progress of olfactory changes in metabolic diseases and the mechanisms

Obesity-Induced Brain Neuroinflammatory and Mitochondrial Changes

Oxidative stress: The nexus of obesity and cognitive dysfunction in diabetes

The Link between Metabolic Syndrome and the Brain

Neuroendocrine-immune Connection between Depression and Metabolic Syndrome

Update on the Relationship Between Depression and Neuroendocrine Metabolism

The hypothalamus for whole-body physiology: from metabolism to aging

Overnutrition Induced Cognitive Impairment: Insulin Resistance, Gut-Brain Axis, and Neuroinflammation

Obesity-induced blood-brain barrier dysfunction: phenotypes and mechanisms

[Nutrition, metabolism, brain and mental health]

[Study on Diabetes-Induced Cognitive Impairment].

The potential biological mechanisms of obesity effects on depression: A systematic review of the literature and knowledge mining